The demonstration that symptoms associated with Rett syndrome could be reversed in mice by postnatal activation of silent MECP2 gene raised the possibility of gene therapy as a potential therapeutic option (Guy et al., 2007). The gene discussed is MECP2; the disease is atypical Rett syndrome.